KURA ONCOLOGY, INC. Current Liabilities
KURA ONCOLOGY, INC. (KURA) had Current Liabilities of $118.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $118.19M.
- 2026-03-31: Liabilities, Current $101.50M.
- 2025-12-31: Liabilities, Current $116.97M.
- 2025-09-30: Liabilities, Current $121.30M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $118.19M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $101.50M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $116.97M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $121.30M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $107.17M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $89.77M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $78.71M 10-K · filed 2026-03-05 |
| 2024-09-30 | $40.37M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $33.45M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $32.27M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $35.26M 10-K · filed 2025-02-28 |
| 2023-09-30 | $27.52M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $23.90M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $19.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $24.06M 10-K · filed 2024-02-27 |
| 2022-09-30 | $24.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $17.87M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $17.73M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $22.45M 10-K · filed 2023-02-23 |
| 2021-09-30 | $21.93M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $21.29M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $25.14M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.02M 10-K · filed 2022-02-24 |
| 2020-09-30 | $21.70M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $18.55M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.55M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $15.56M 10-K · filed 2021-02-24 |
| 2019-09-30 | $13.11M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $11.23M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $12.14M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $13.62M 10-K · filed 2020-02-25 |
| 2018-09-30 | $12.90M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $12.58M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $11.35M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $10.03M 10-K · filed 2019-03-05 |
| 2017-09-30 | $7.56M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $5.08M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.12M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $5.45M 10-K · filed 2018-03-12 |
| 2016-09-30 | $5.27M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.38M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $4.31M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $5.05M 10-K · filed 2017-03-14 |
| 2015-09-30 | $4.71M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $3.60M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $5.53M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $3.02M 10-K · filed 2016-03-17 |
| 2013-03-31 | $105.34K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $103.65K 10-Q · filed 2013-05-15 |
| 2012-09-30 | $97.14K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $95.40K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $97.77K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $74.75K 10-K · filed 2013-03-28 |
| 2011-09-30 | $69.68K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $68.39K 10-Q · filed 2011-08-15 |
| 2011-03-31 | $74.75K 10-Q · filed 2012-05-15 |
| 2010-12-31 | $70.39K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |